CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
CANADA

About Us

Conference

Partner With Us

  • APAC
    • US
    • EUROPE
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    Bioinformatics & Genomics
    BioTech
    Cell and Gene Therapy
    Drug Discovery and Development
    Life Science AI
    Next-Generation Sequencing
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    CDMO
    Cosmetic
    CRO
    Life Science Testing And Compliance
    Supplement Manufacturing
  • Business Services
    Life Science Consulting
    Life Sciences Marketing and Communication
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • Clinical Stage Biopharmaceutical
  • Top Clinical-Stage Biopharmaceutical Companies in APAC

Clinical Stage Biopharmaceutical 2022

Top 10 Clinical-Stage Biopharmaceutical Companies in APAC - 2022

Top 10 Clinical-Stage Biopharmaceutical Companies in APAC - 2022

Clinical trials are part of clinical research that follow strict protocols to obtain data about new drug development's safety and efficacy, leading to its approval for market release. The APAC region is the most significant contributor accounting for more than fifty percent of global clinical trials. Over the forecast period of 2022-27, the size of the market is estimated to increase at a CAGR of 8.9 percent.

Technological advancements and increased demand for innovative healthcare solutions are the main reasons for this market growth. Artificial intelligence and machine learning are being used predominantly to find potential candidates for drug trials. Also, the demand for innovative solutions has led numerous biopharmaceuticals to partner with academic research centers, especially for early clinical development. This has steered the shift of focus on developing solutions to treat rare and terminal diseases. Furthermore, emerging nations are more cost competitive than developed ones, further strengthening this argument.

In this edition of Life Sciences Review, we present you with the list of the top ten clinical-stage biopharmaceutical companies in the APAC market space which are at the forefront of innovation in the region's clinical-stage biopharmaceutical arena. Stewart Campbell, VP & General Manager, West AP and Li Chen, VP & General Manager, West Biologics, have shared their viewpoints to Life Sciences Review APAC on the various aspects of the industry. Additionally, companies like Accro Bioscience, Adagene, and Forest Hill Labs, with their top-notch R&D and solutions are opening doors to new possibilities in the clinical-stage biopharmaceutical sector. Life Sciences Review APAC also presents you with exclusive insights and thought pieces from expert CIOs and CXOs - Chris Braithwaite, SVP and Global Head of Drug Development Technology at Novartis, Hua Gong, M.D., Ph.D., SVP, Global Head of Translational Medicine and Clinical Biomarker, Zai Lab, discussing and providing their ideas on the trends currently practiced in the industry. We hope these valuable insights from industry leaders and solutions from leading solution providers featured in this edition will assist you in making informed decisions for your businesses.

Top 10 Clinical-Stage Biopharmaceutical Companies in APAC - 2022

Nominate a Company

Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.

* 

captcha
Can't read the image? click here to refresh

Thank You!

checkmark

We are glad to receive your nomination. Our editorial team and evaluation panel will review your submission. Thank you for taking the time to highlight an organization driving impactful change in Lifescience Review.

Data not inserted

    Top Clinical-Stage Biopharmaceutical Companies in APAC

    ★Featured Companies
    Accro Bioscience
    Accro Bioscience
    Read full profile →
    Dr. Sudan He, Scientific Advisor and Co-founder of Accro Bioscience ... read full profile
    Forest Hills Lab
    Forest Hills Lab
    Read full profile →
    Forest Hills Lab is an innovative regenerative medicine company seeking to improve the quality of life of our rapidly aging society and comprised of two divisions: Neuro-Med division is a therapeutic drug development platform focused on neurodegenerative diseases with high unmet need while Cos-Med division develops and markets a comprehensive line of aesthetics products globally. ... read full profile
    Adagene
    Adagene
    Adagene is a Nasdaq-listed, international, clinical-stage immunotherapy firm that is reinventing antibody discovery and design to pave the way for future advancements in the fight against cancer. Programme pipeline at Adagene is being driven by its discovery engine, Dynamic Precision Library, which has the potential to be the first or best in class
    Antengene Corporation
    Antengene Corporation
    Antengene is an R&D-driven biopharmaceutical firm with a global emphasis on creating novel cancer treatments for people everywhere. establishing completely integrated capabilities in clinical development, production, and commercialization to encourage the quick clinical uptake of novel medicines from throughout the world
    Everest Medicines
    Everest Medicines
    Everest Medicines is a biopharmaceutical business that specialises on creating and marketing revolutionary pharmaceuticals that address significant unmet medical needs for patients in Asian countries. Eleven medicines from Everest Medicines' portfolio, many of which are in late-stage clinical development, have the potential to be first-in-class or best-in-class around the globe
    Hansoh Pharmaceutical
    Hansoh Pharmaceutical
    A leading biopharmaceutical company in Asia, Hansoh Pharma is dedicated to enhancing human health through ongoing innovation. The company is dynamically aligned with the global advanced access level by continuously designing and constructing production facilities and lines in accordance with international advanced standards and using advanced production tools
    HUTCHMED
    HUTCHMED
    Hutchmed is a biopharmaceutical business in the commercial stage, and is dedicated to the global discovery and development of targeted therapeutics and immunotherapies for the treatment of cancer and immunological illnesses. It is one of the first with a global focus on innovative drug discovery
    Simcere
    Simcere
    Simcere Pharma is dedicated to collaborative innovation and is driven by innovative R&D. The company's focus is on the three key areas of tumour, nervous system, and autoimmune with the goal of enabling patients to use more effective medications, while also actively and prospectively deploying illness areas with significant clinical requirements in the future
    Telix Pharmaceuticals
    Telix Pharmaceuticals
    Telix is a multinational, commercial-stage biopharmaceutical company that specialises in the development of targeted radiation-based diagnostic and therapeutic products. A trustworthy and secure worldwide supply chain, manufacturing, and distribution network supports Telix's extensive pipeline for prostate, kidney, brain (glioblastoma), and hematologic malignancies as well as uncommon disorders
    Zai Lab
    Zai Lab
    Zai Lab is a global biopharmaceutical company that focuses on providing quality medicine for oncology and various diseases. it has a clinical development team cosisting of physicians with expertise in pharmaceutical development in their therapeutic areas
Life Sciences Review APAC
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review APAC. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://clinical-stage-biopharmaceutical-apac.lifesciencesreviewapac.com/vendors/top-clinical-stage-biopharmaceutical-companies-in-apac-2022.html